Patrick Donnelly
Stock Analyst at Citigroup
(5.00)
# 7
Out of 4,827 analysts
328
Total ratings
49.71%
Success rate
160.56%
Average return
Main Sectors:
Stocks Rated by Patrick Donnelly
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BIO Bio-Rad Laboratories | Maintains: Buy | $400 → $350 | $231.57 | +51.14% | 15 | May 2, 2025 | |
| BIO.B Bio-Rad Laboratories | Maintains: Buy | $400 → $350 | $234.41 | +49.31% | 15 | May 2, 2025 | |
| ILMN Illumina | Maintains: Neutral | $90 → $85 | $74.53 | +14.05% | 16 | Apr 7, 2025 | |
| ICLR ICON Public Limited Company | Maintains: Buy | $290 → $215 | $135.16 | +59.07% | 9 | Apr 7, 2025 | |
| BRKR Bruker | Maintains: Buy | $75 → $50 | $39.49 | +26.61% | 15 | Apr 7, 2025 | |
| MTD Mettler-Toledo International | Upgrades: Buy | $1,400 | $1,063.37 | +31.66% | 13 | Apr 7, 2025 | |
| TXG 10x Genomics | Maintains: Buy | $20 → $15 | $8.12 | +84.73% | 12 | Mar 4, 2025 | |
| AVTR Avantor | Maintains: Neutral | $22 → $18 | $11.98 | +50.25% | 8 | Mar 4, 2025 | |
| TECH Bio-Techne | Maintains: Neutral | $80 → $70 | $47.76 | +46.57% | 11 | Mar 4, 2025 | |
| HOLX Hologic | Maintains: Neutral | $80 → $70 | $53.17 | +31.65% | 14 | Mar 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $225 → $210 | $146.16 | +43.68% | 10 | Mar 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $650 → $570 | $407.02 | +40.04% | 19 | Mar 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $185 | $176.11 | +5.05% | 11 | Mar 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Neutral | $155 → $175 | $115.24 | +51.86% | 20 | Mar 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $285 → $265 | $190.05 | +39.44% | 12 | Jan 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $30 → $23 | $5.51 | +317.42% | 4 | Dec 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $44 → $50 | $25.94 | +92.75% | 4 | Dec 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $18 → $20 | $12.87 | +55.46% | 3 | Nov 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $80 → $75 | $53.99 | +38.91% | 13 | Nov 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $150 → $165 | $105.24 | +56.78% | 26 | Aug 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $40 → $45 | $41.99 | +7.17% | 9 | Aug 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $30 → $28 | $21.26 | +31.70% | 4 | Aug 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $135 → $145 | $90.51 | +60.20% | 1 | Jul 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $64 → $62 | $42.19 | +46.48% | 13 | Feb 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $265 → $300 | $339.17 | -11.55% | 24 | Dec 11, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $7 → $9 | $2.82 | +219.15% | 6 | Dec 11, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $3.75 → $2.75 | $2.54 | +8.27% | 4 | Aug 10, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $250 → $260 | $244.20 | +6.47% | 11 | Feb 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $8 → $6 | $4.07 | +47.42% | 4 | Nov 3, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Neutral | $28 → $32 | $7.28 | +339.56% | 2 | Nov 30, 2018 |
Bio-Rad Laboratories
May 2, 2025
Maintains: Buy
Price Target: $400 → $350
Current: $231.57
Upside: +51.14%
Bio-Rad Laboratories
May 2, 2025
Maintains: Buy
Price Target: $400 → $350
Current: $234.41
Upside: +49.31%
Illumina
Apr 7, 2025
Maintains: Neutral
Price Target: $90 → $85
Current: $74.53
Upside: +14.05%
ICON Public Limited Company
Apr 7, 2025
Maintains: Buy
Price Target: $290 → $215
Current: $135.16
Upside: +59.07%
Bruker
Apr 7, 2025
Maintains: Buy
Price Target: $75 → $50
Current: $39.49
Upside: +26.61%
Mettler-Toledo International
Apr 7, 2025
Upgrades: Buy
Price Target: $1,400
Current: $1,063.37
Upside: +31.66%
10x Genomics
Mar 4, 2025
Maintains: Buy
Price Target: $20 → $15
Current: $8.12
Upside: +84.73%
Avantor
Mar 4, 2025
Maintains: Neutral
Price Target: $22 → $18
Current: $11.98
Upside: +50.25%
Bio-Techne
Mar 4, 2025
Maintains: Neutral
Price Target: $80 → $70
Current: $47.76
Upside: +46.57%
Hologic
Mar 4, 2025
Maintains: Neutral
Price Target: $80 → $70
Current: $53.17
Upside: +31.65%
Mar 4, 2025
Maintains: Neutral
Price Target: $225 → $210
Current: $146.16
Upside: +43.68%
Mar 4, 2025
Maintains: Neutral
Price Target: $650 → $570
Current: $407.02
Upside: +40.04%
Mar 4, 2025
Downgrades: Neutral
Price Target: $185
Current: $176.11
Upside: +5.05%
Mar 4, 2025
Upgrades: Neutral
Price Target: $155 → $175
Current: $115.24
Upside: +51.86%
Jan 30, 2025
Maintains: Buy
Price Target: $285 → $265
Current: $190.05
Upside: +39.44%
Dec 11, 2024
Downgrades: Neutral
Price Target: $30 → $23
Current: $5.51
Upside: +317.42%
Dec 11, 2024
Upgrades: Buy
Price Target: $44 → $50
Current: $25.94
Upside: +92.75%
Nov 6, 2024
Maintains: Buy
Price Target: $18 → $20
Current: $12.87
Upside: +55.46%
Nov 6, 2024
Maintains: Buy
Price Target: $80 → $75
Current: $53.99
Upside: +38.91%
Aug 22, 2024
Maintains: Buy
Price Target: $150 → $165
Current: $105.24
Upside: +56.78%
Aug 8, 2024
Maintains: Buy
Price Target: $40 → $45
Current: $41.99
Upside: +7.17%
Aug 7, 2024
Maintains: Buy
Price Target: $30 → $28
Current: $21.26
Upside: +31.70%
Jul 30, 2024
Maintains: Buy
Price Target: $135 → $145
Current: $90.51
Upside: +60.20%
Feb 8, 2024
Maintains: Buy
Price Target: $64 → $62
Current: $42.19
Upside: +46.48%
Dec 11, 2023
Maintains: Neutral
Price Target: $265 → $300
Current: $339.17
Upside: -11.55%
Dec 11, 2023
Maintains: Buy
Price Target: $7 → $9
Current: $2.82
Upside: +219.15%
Aug 10, 2023
Maintains: Neutral
Price Target: $3.75 → $2.75
Current: $2.54
Upside: +8.27%
Feb 17, 2023
Maintains: Neutral
Price Target: $250 → $260
Current: $244.20
Upside: +6.47%
Nov 3, 2022
Maintains: Buy
Price Target: $8 → $6
Current: $4.07
Upside: +47.42%
Nov 30, 2018
Upgrades: Neutral
Price Target: $28 → $32
Current: $7.28
Upside: +339.56%